Levodopa BP97/CP2010/USP36
1. Source: Mucuna macrocarpa
2. Content: 99%
3. CAS NO: 59-92-7
4. Standard: BP & GMP
5. Function: Parkinsonism
| Item |
Standard |
Result |
| Content |
99.00%-101.00% |
99.29% |
| Characters |
A white or slightly cream-coloured, crystalline powder |
White crystalline powder
|
| Solubility |
Slightly soluble in water, practically insoluble in alcohol and in ether |
Meets the requirements |
| Appearance of solution |
Meets the requirements |
Meets the requirements |
| Acidity of alkalinity |
PH: 4.50~7.00 |
5.25 |
| Optical rotation |
-1.27°~ -1.34° |
-1.30° |
| Absorbance |
137.0~147.0 |
141.3 |
| Related substances |
≤0.50% |
0.39% |
| Heavy metals |
≤10ppm |
5ppm |
| Loss on drying |
≤1.00% |
0.47% |
| Sulphated ash |
≤0.10% |
0.05% |
| Density/Particle size |
100mesh |
100mesh |
| Conclusion: The quality of above commodity complies with BP2005 Standard. |
Levodopa is a medication used to treat Parkinson's disease. Parkinson's disease is associated with low levels of a chemical called dopamine (doe PA meen) in the brain. Levodopa is turned into dopamine in the body and therefore increases levels of this chemical.
Levodopa is used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease. Levodopa is also used to treat these same muscular conditions when they are caused by drugs such as chlorpromazine (Thorazine), fluphenazine (Prolixin), perphenazine (Trilafon), and others.
Levodopa may also be used for purposes other than those listed in this medication guide.
Physical & Chemical properties
- A white or white crystalline powder
- Odorless, tasteless
- Slightly soluble in water
- Insoluble in chloroform, ethanol or ether
-Soluble in acid solution
Properties
1. Pharmacology
Treat parkinsonism and Parkinsonism syndrome
Treat hepatic coma, hub functions to improve the patient awake, symptom improvement
2. Food
Promote sleep
Reduce fat
Increase bone density and reversal of osteoporosis
Increase muscle strength
Enhance the role of sexual health
Uses recommendation
1. Medicinal: 0.5-1.0 g/day
2. Food supplement: 200-300mg/day
Levodopa (L-Dopa) is an amino acid precursor of dopamine and is the most effective and commonly used drug in the treatment of Parkinson disease. Levodopa is usually combined with carbidopa, which is an inhibitor of L-amino acid decarboxylase, the plasma enzyme that metabolizes levodopa peripherally. Treatment with the combination of levodopa and carbidopa has been associated with mild and transient increases in serum enzymes in a proportion of treated patients and with very rare instances of clinically apparent acute liver injury.
Mucuna Pruriens Extract: Levodopa 20%
Methyldopa tablets
DL-Methyldopa
Carbidopa
*******************************************************************************
To get more information, just feel free to contact with us. Thanks.
Mr. Liu
Qingdao fraken international trading co., ltd
Address: RM1005 post mansion yan'an three road, qingdao, China
Tel: 0086 532 83899718
Fax: 0086 532 83623236
Web: http://fraken.en.made-in-china.com/
Audited Supplier 
){kind=link}